Andrew Sharples to speak at One Nucleus event

No items found.
​
21 January 2013
Tags
Life
Table of contents
  • Toc Heading
  • Toc Heading

Partner Andrew Sharples, the head of EIP Life, will give a talk at a One Nucleus event which focuses on antibody-based therapeutics.

The Life Science Leadership Series event is hosted by the life sciences business network One Nucleus, and takes place at the Babraham Research Campus in Cambridge on 23 January.

Andrew’s talk is entitled ‘Assessing freedom to operate in the antibody-drug conjugation (ADC) arena’. Click here for the full programme.

The One Nucleus Leadership Series features one-day events that focus by therapeutic or technology area, and include a programme of presentations, partnering and networking opportunities for the life sciences community.

Related articles

See all articles

EIP recognsied for strategic leadership in patent law at the Professional Services Management Excellence Awards
26 March 2026
EIP has been recognised with two Professional Services Management Excellence Awards 2026, including Excellence in Strategic Leadership and Best in Theme: Leadership. The awards reflect the firm’s commitment to aligning patent expertise with commercial insight, strengthening leadership across the firm and delivering patent strategy that supports investment, growth and high‑value business decisions.
​
EIP promotes Callum Docherty to Principal in the US
19 March 2026
EIP is pleased to announce the promotion of Callum Docherty to Principal, recognizing his substantial contribution to the firm’s international patent practice and his leadership within EIP’s growing US team.
​
EIP announces the promotion of Rob Barker to Partner
12 March 2026
EIP is pleased to announce the promotion of Robert Barker to Partner, recognising his significant contribution to the firm’s Digital, Chemistry, Life Sciences, and multidisciplinary patent practice since joining in 2014.
​